Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients. (Q53622264)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients. |
scientific article |
Statements
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients. (English)
Bhuvaneswari Ramaswamy
Anthony D Elias
Nicole T Kelbick
Angela Dodley
Mark Morrow
Marsha Hauger
Joan Allen
Chris Rhoades
Kari Kendra
Helen X Chen
S Gail Eckhardt
Charles L Shapiro
1 May 2006
12
10
3124-3129